首页|Mitophagy in acute central nervous system injuries:regulatory mechanisms and therapeutic potentials

Mitophagy in acute central nervous system injuries:regulatory mechanisms and therapeutic potentials

扫码查看
原文链接
  • 万方数据
  • 维普
Acute central nervous system injuries,including ischemic stroke,intracerebral hemorrhage,subarachnoid hemorrhage,traumatic brain injury,and spinal cord injury,are a major global health challenge.Identifying optimal therapies and improving the long-term neurological functions of patients with acute central nervous system injuries are urgent priorities.Mitochondria are susceptible to damage after acute central nervous system injury,and this leads to the release of toxic levels of reactive oxygen species,which induce cell death.Mitophagy,a selective form of autophagy,is crucial in eliminating redundant or damaged mitochondria during these events.Recent evidence has highlighted the significant role of mitophagy in acute central nervous system injuries.In this review,we provide a comprehensive overview of the process,classification,and related mechanisms of mitophagy.We also highlight the recent developments in research into the role of mitophagy in various acute central nervous system injuries and drug therapies that regulate mitophagy.In the final section of this review,we emphasize the potential for treating these disorders by focusing on mitophagy and suggest future research paths in this area.

autophagyintracerebral hemorrhageischemic strokemitochondriamitochondrial biogenesismitochondrial quality controlmitophagyspinal cord injurysubarachnoid hemorrhagetraumatic brain injury

Siyi Xu、Junqiu Jia、Rui Mao、Xiang Cao、Yun Xu

展开 >

Department of Neurology,Nanjing Drum Tower Hospital,Clinical College of Jiangsu University,Nanjing,Jiangsu Province,China

Department of Neurology,Nanjing Drum Tower Hospital,Chinese Academy of Medical Science & Peking Union Medical College,Nanjing,Jiangsu Province,China

Department of Neurology,Nanjing Drum Tower Hospital,Affiliated Hospital of Medical School,Nanjing University,Nanjing,Jiangsu Province,China

State Key Laboratory of Pharmaceutical Biotechnology and Institute of Translational Medicine for Brain Critical Diseases,Nanjing University,Nanjing,Jiangsu Province,China

Jiangsu Key Laboratory for Molecular Medicine,Medical School of Nanjing Univers

State Key Laboratory of Pharmaceutical Biotechnology and Institute of Translational Medicine for Brai

展开 >

2025

10.4103/NRR.NRR-D-24-00432

中国神经再生研究(英文版)
中国康复医学会

中国神经再生研究(英文版)

影响因子：0.902
ISSN：1673-5374
年,卷(期)：2025.20(9)